Suchergebnisse - "Zhu, Sha"

PubPharm (8)

1

Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer

enthalten in: Journal of cancer research and clinical oncology | 2023

von Xu, N. | Zhao, J. | Zhao, F. | +26

2

Mutations in epigenetic regulator KMT2C detected by liquid biopsy are associated with worse survival in prostate cancer patients

enthalten in: Oncology research | 2023

von Zhu, S. | Xu, N. | Liang, J. | +10

3

A dual-readout sandwich immunoassay based on biocatalytic perovskite nanocrystals for detection of prostate specific antigen

enthalten in: Biosensors & bioelectronics | 2022

von Li, M. | Wang, Y. | Hu, H. | +4

4

Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients : Association with patient outcome under abiraterone

enthalten in: Cancer medicine | 2021

von Zhu, S. | Ni, Y. | Sun, G. | +12

5

Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients

enthalten in: The Prostate | 2021

von Zhu, S. | Chen, J. | Ni, Y. | +18

6

Intraductal carcinoma of the prostate in prostate biopsy samples : correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer

enthalten in: Asian journal of andrology | 2020

von Zhu, S. | Zhao, J. | Chen, J. | +7

7

Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer

enthalten in: Asian journal of andrology | 2020

von Chen, J. | Zhao, J. | Zhu, S. | +6

8

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer : a systematic review and meta-analysis

enthalten in: World journal of surgical oncology | 2020

von Wang, Z. | Ni, Y. | Chen, J. | +9

1
[1]